gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Veterinary Molecular Diagnostic Market By Product Type (Instruments and Consumables {Reagents, Kits and Others), By Technology (Polymerase Chain Reaction, INAAT, Microarrays and DNA Sequencing), By Animal Type (Companion Animals {Dogs, Horses and Cats} and Livestock Animals {Pigs, Cattles, Poultry and Others}), By End-Users (Veterinary Hospitals, Clinical Laboratories and Research Institutes) and by Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : Published Date: November-2018 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


The veterinary molecular diagnostic utilizes various type of technique such as nucleic acid diagnostic techniques, biochips, DNA Sequencing, etc to detect the presence of nucleic acids (DNA/RNA) from pathogenic organisms in clinical samples of animals. A wide variety of tests are available for bacteria, fungi, and viruses from many animal species, including pathogens of cattle, cats, dogs, horses, and others. Nucleic acid diagnostic techniques such as polymerase chain reaction (PCR) is widely adopted molecular diagnostic tools used for animals to rapidly screen large numbers of samples during disease outbreaks. For instance, European Food Safety Authority stated that approximately 320,000 cases of foodborne and zoonotic diseases are reported each year across the globe.

Rising prevalence of zoonotic disease, increasing diagnosis rate due to the rise in spending on animal health care are the major driving factors which are expected to boost the growth of veterinary molecular diagnostic market during the forecast period. In addition, the introduction of innovative veterinary diagnostic, and rise in foodborne disease is expected to be one of the crucial reasons for the growth of veterinary molecular diagnostic market. Moreover, increasing penetration of molecular diagnostics for veterinary due to the presence of strong distribution channel, rising urbanization, and with high disposable incomes pet owners frequently visit the veterinary facilities are some of the factors boosting the growth of this market. However, the dearth of the skilled veterinary practitioner and low awareness regarding veterinary molecular diagnostic in developed and developing countries acts as a restraining factor for the market.

Various notable players operating in the market, Thermo Fisher Scientific Inc., QIAGEN N.V., IDEXX Laboratories Inc., VCA Inc., Biomedica Medizinprodukte GmbH & Co. KG, HealthGene Corporation, Bioneer, ABAXIS Inc, Neogen Corporation among others. Most of the company are focusing on strategic collaboration with the animal health care service provider to increase the penetration of veterinary molecular diagnostic in emerging economies such as China, India, Brazil, etc.

The global veterinary molecular diagnostic market has been segmented based on product type, technology, animal, end-use, and key geographies. Based on product type, the market comprises of instruments and consumables. The research report “global veterinary molecular diagnostic market” provides in-depth analysis of global veterinary molecular diagnostic market based on product type, technology, animal type, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global veterinary molecular diagnostic market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.


Key questions answered in this research report:
1-    At what pace is veterinary molecular diagnostic market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the veterinary molecular diagnostic market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation
By Product Type

•    Instruments 
•    Consumables
o    Reagents
o    Kits
o    Others
 

By Technology
•    PCR
•    INAAT
•    Microarrays
•    DNA Sequencing
 

By Animal type
•    Companion Animals
o    Dogs
o    Horses
o    Cats
•    Livestock Animals
o    Pigs
o    Cattles
o    Poultry
o    Others
 

By End-Users
•    Veterinary Hospitals
•    Clinical Laboratories
•    Research Institutes
 

By Geography
•    North America
As a part of customization
o    By Product Type
o    By Technology
o    By Animal Type
o    By End users
o    US
o    Canada
o    Mexico
 

•    Europe
As a part of customization
o    By Product Type
o    By Technology
o    By Animal Type
o    By End users
o    UK
o    Germany
o    Spain
o    Rest of Europe
 

•    Asia-Pacific
As a part of customization
o    By Product Type
o    By Technology
o    By Animal Type
o    By End users
o    China
o    Australia
o    India
o    Rest of APAC
 

•    ROW
As a part of customization
o    By Product Type
o    By Technology
o    By Animal Type
o    By End users
o    Brazil
o    South Africa
o    GCC countries
o    Rest of world (remaining countries of the LAMEA region)
 

Leading market players
•    Thermo Fisher Scientific Inc.
•    QIAGEN N.V.
•    IDEXX Laboratories Inc.
•    VCA Inc.
•    Biomedica Medizinprodukte GmbH & Co. KG
•    HealthGene Corporation
•    Bioneer
•    ABAXIS Inc.
•    Neogen Corporation


*Other prominent players in the market which can be profiled as a part of customization:
Zoetis, Inc.
Virbac SA,
HESKA Corporation
Veterinary Molecular Diagnostics, Inc.

1.    Executive Summary

 

2.    Introduction           
       2.1.    Study Objectives       
       2.2.    Market Definition       
                  2.2.1.     Market Covered   
                  2.2.2.    Geographical Coverage   
                  2.2.3.    Study Years & Currency   
       2.3.    Market Stakeholders       
       2.4.    Key Questions this Study will Answer       
       2.5.    GMI Research’s Approach & Methodology  
 

 

3.    Global Veterinary Molecular Diagnostic Market - Overview           
       3.1.    Introduction         `
       3.2.    Market Segmentation       
       3.3.    Value Chain Analysis       
       3.4.    Drivers       
       3.5.    Restraints       
       3.6.    Trends     
 

 

4.    Global Veterinary Molecular Diagnostic Market Revenue Forecast till 2025    

 

5.    Global Veterinary Molecular Diagnostic Market by Product Type Revenue Forecast till 2025           
       5.1.    Instruments 
       5.2.    Consumables
                  5.2.1.    Reagents
                  5.2.2.    Kits
                  5.2.3.    Others
 

 

6.    Global Veterinary Molecular Diagnostic Market by Technology Revenue Forecast till 2025           
       6.1.    PCR
       6.2.    INAAT
       6.3.    Microarrays
       6.4.    DNA Sequencing
 

 

7.    Global Veterinary Molecular Diagnostic Market by Animal Type Revenue Forecast till 2025           
       7.1.    Companion Animals
                  7.1.1.    Dogs
                  7.1.2.    Horses
                  7.1.3.    Cats
       7.2.    Livestock Animals
                  7.2.1.    Pigs
                  7.2.2.    Cattles
                  7.2.3.    Poultry
                  7.2.4.    Others 
 

 

8.    Global Veterinary Molecular Diagnostic Market by End User Revenue Forecast till 2025           
       8.1.    Veterinary Hospitals
       8.2.    Clinical Laboratories
       8.3.    Research Institutes
 

 

9.    Global Veterinary Molecular Diagnostic Market by Geography Revenue Forecast till 2025
       9.1.    North America Veterinary Molecular Diagnostic Market Revenue Forecast till 2025       
                  9.1.1.    North America Veterinary Molecular Diagnostic Market by Product Type

                                (Option 1: 25% customization)
                                9.1.1.1.    Instruments  
                                9.1.1.2.    Consumables
                                9.1.1.3.    Injectable Devices
                                                 9.1.1.3.1.    Reagents
                                                 9.1.1.3.2.    Kits
                                                 9.1.1.3.3.    Others
                  9.1.2.    North America Veterinary Molecular Diagnostic Market by Technology
                                9.1.2.1.    PCR
                                9.1.2.2.    INAAT
                                9.1.2.3.    Microarrays
                                9.1.2.4.    DNA Sequencing
                  9.1.3.    North America Veterinary Molecular Diagnostic Market by Animal Type
                                9.1.3.1.    Companion Animals
                                                 9.1.3.1.1.    Dogs
                                                 9.1.3.1.2.    Horses
                                                 9.1.3.1.3.    Cats
                                9.1.3.2.    Livestock Animals
                                                 9.1.3.2.1.    Pigs
                                                 9.1.3.2.2.    Cattles
                                                 9.1.3.2.3.    Poultry
                                                 9.1.3.2.4.    Others
                  9.1.4.    North America Veterinary Molecular Diagnostic Market by End User   
                                9.1.4.1.    Veterinary Hospitals
                                9.1.4.2.    Clinical Laboratories
                                9.1.4.3.    Research Institutes

       9.2.    Europe Veterinary Molecular Diagnostic Market Revenue Forecast till 2025       
                  9.2.1.    Europe Veterinary Molecular Diagnostic Market by Product Type

                                (Option 2: 25% customization)
                                9.2.1.1.    Instruments  
                                9.2.1.2.    Consumables
                                9.2.1.3.    Injectable Devices
                                                 9.2.1.3.1.    Reagents
                                                 9.2.1.3.2.    Kits
                                                 9.2.1.3.3.    Others

                  9.2.2.    Europe Veterinary Molecular Diagnostic Market by Technology
                                9.2.2.1.    PCR
                                9.2.2.2.    INAAT
                                9.2.2.3.    Microarrays
                                9.2.2.4.    DNA Sequencing
                  9.2.3.    Europe Veterinary Molecular Diagnostic Market by Animal Type
                                9.2.3.1.    Companion Animals
                                                 9.2.3.1.1.    Dogs
                                                 9.2.3.1.2.    Horses
                                                 9.2.3.1.3.    Cats
                                9.2.3.2.    Livestock Animals
                                                 9.2.3.2.1.    Pigs
                                                 9.2.3.2.2.    Cattles
                                                 9.2.3.2.3.    Poultry
                                                 9.2.3.2.4.    Others
                  9.2.4.    Europe Veterinary Molecular Diagnostic Market by End User   
                                9.2.4.1.    Veterinary Hospitals
                                9.2.4.2.    Clinical Laboratories
                                9.2.4.3.    Research Institutes
 
       9.3.    Asia-Pacific Veterinary Molecular Diagnostic Market Revenue Forecast till 2025       
                  9.3.1.    Asia-Pacific Veterinary Molecular Diagnostic Market by Product Type

                                (Option 3: 25% customization)
                                9.3.1.1.    Instruments  
                                9.3.1.2.    Consumables
                                9.3.1.3.    Injectable Devices
                                                 9.3.1.3.1.    Reagents
                                                 9.3.1.3.2.    Kits
                                                 9.3.1.3.3.    Others

                  9.3.2.    Asia-Pacific Veterinary Molecular Diagnostic Market by Technology
                                9.3.2.1.    PCR
                                9.3.2.2.    INAAT
                                9.3.2.3.    Microarrays
                                9.3.2.4.    DNA Sequencing

                  9.3.3.    Asia-Pacific Veterinary Molecular Diagnostic Market by Animal Type
                                9.3.3.1.    Companion Animals
                                                 9.3.3.1.1.    Dogs
                                                 9.3.3.1.2.    Horses
                                                 9.3.3.1.3.    Cats
                                9.3.3.2.    Livestock Animals
                                                 9.3.3.2.1.    Pigs
                                                 9.3.3.2.2.    Cattles
                                                 9.3.3.2.3.    Poultry
                                                 9.3.3.2.4.    Others

                  9.3.4.    Asia-Pacific Veterinary Molecular Diagnostic Market by End User   
                                9.3.4.1.    Veterinary Hospitals
                                9.3.4.2.    Clinical Laboratories
                                                 Research Institutes

       9.4.    Rest of the World Veterinary Molecular Diagnostic Market Revenue Forecast till 2025       
                  9.4.1.    Rest of the World Veterinary Molecular Diagnostic Market by Product Type

                                (Option 4: 25% customization)
                                9.4.1.1.    Instruments  
                                9.4.1.2.    Consumables
                                9.4.1.3.    Injectable Devices
                                                 9.4.1.3.1.    Reagents
                                                 9.4.1.3.2.    Kits
                                                 9.4.1.3.3.    Others

                  9.4.2.    Rest of the World Veterinary Molecular Diagnostic Market by Technology
                                9.4.2.1.    PCR
                                9.4.2.2.    INAAT
                                9.4.2.3.    Microarrays
                                9.4.2.4.    DNA Sequencing

                  9.4.3.    Rest of the World Veterinary Molecular Diagnostic Market by Animal Type
                                9.4.3.1.    Companion Animals
                                                 9.4.3.1.1.    Dogs
                                                 9.4.3.1.2.    Horses
                                                 9.4.3.1.3.    Cats
                                9.4.3.2.    Livestock Animals
                                                 9.4.3.2.1.    Pigs
                                                 9.4.3.2.2.    Cattles
                                                 9.4.3.2.3.    Poultry
                                                 9.4.3.2.4.    Others

                  9.4.4.    Rest of the World Veterinary Molecular Diagnostic Market by End User   
                                9.4.4.1.    Veterinary Hospitals
                                9.4.4.2.    Clinical Laboratories
                                9.4.4.3.    Research Institutes
 

 

10.    Competitive Landscape           
          10.1.    Competitive Landscape
          10.2.    Porter 5 Analysis
          10.3.    Major players and their key strategies
          10.4.    Company Share Analysis     

 

11.    Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of

          your Choice)
          11.1.    Thermo Fisher Scientific Inc.      
                       11.1.1.    Company Overview   
                       11.1.2.    Financials   
                       11.1.3.    Recent Developments   
          11.2.    QIAGEN N.V.      
                       11.2.1.    Company Overview   
                       11.2.2.    Financials   
                       11.2.3.    Recent Developments   
          11.3.    IDEXX Laboratories Inc.    
                       11.3.1.    Company Overview   
                       11.3.2.    Financials   
                       11.3.3.    Recent Developments   
          11.4.    VCA Inc.        
                       11.4.1.    Company Overview   
                       11.4.2.    Financials   
                       11.4.3.    Recent Developments   
          11.5.    Biomedica Medizinprodukte GmbH & Co. KG        
                       11.5.1.    Company Overview   
                       11.5.2.    Financials   
                       11.5.3.    Recent Developments   
          11.6.    HealthGene Corporation       
                       11.6.1.    Company Overview   
                       11.6.2.    Financials   
                       11.6.3.    Recent Developments   
          11.7.    Bioneer        
                       11.7.1.    Company Overview   
                       11.7.2.    Financials   
                       11.7.3.    Recent Developments   
          11.8.    ABAXIS Inc.      
                       11.8.1.     Company Overview   
                       11.8.2.    Financials   
                       11.8.3.    Recent Developments   
          11.9.    Neogen Corporation
                       11.9.1.    Company Overview   
                       11.9.2.    Financials   
                       11.9.3.    Recent Developments
          11.10.    Veterinary Molecular Diagnostics, Inc.
                       11.10.1.    Company Overview   
                       11.10.2.    Financials   
                       11.10.3.    Recent Developments
 

12.    About GMI Research